EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reimagining the contribution of iron in Parkinson's disease

Rebecka O Serpa, Emily Tufano, James R Connor

Neurobiology of Disease · 2026-07 · 225 · 107434

DOI: 10.1016/j.nbd.2026.107434 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurobiology of Disease, 2026-07. Verfasst von Rebecka O Serpa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Pennsylvania State University College of Medicine, Hershey, PA, USA; Penn State Neuroscience Institute, The Pennsylva…. Hauptthemen laut MEDLINE: Parkinson Disease, Iron. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Center for Advancing Translational Sciences, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's Disease (PD) is the fastest-growing neurodegenerative disease globally, with prevalence increasing more rapidly than Alzheimer's disease. PD pathogenesis has traditionally been framed around iron accumulation in the substantia nigra (SN), resulting in oxidative injury to vulnerable dopaminergic neurons. However, excess iron alone does not readily explain the temporal emergence of dopaminergic susceptibility across the lifespan. Epidemiological and clinical studies consistently show that iron deficiency often precedes PD diagnosis by more than a decade, suggesting that early iron dysregulation establishes a prodromal metabolic state that destabilizes the nigrostriatal system. Here we propose a dynamic two-phase framework in which iron deficiency establishes a latent vulnerability state characterized by impaired iron-dependent enzymatic activity, diminished ferritin buffering, weakened mitochondrial function, and reduced antioxidant defenses. In this primed context, subsequent increases in dopaminergic flux during L-DOPA therapy may amplify oxidative stress by elevating cytosolic dopamine, perturbing iron handling, and promoting dopamine iron redox chemistry that generates quinones and reactive oxygen species (ROS). Transitions in iron availability including iron supplementation, may further aggravate this process but are not required for its initiation. By reframing PD as a disorder shaped by dynamic changes in iron availability interacting with dopaminergic demand, this review integrates evidence across iron biology, dopaminergic signaling, oxidative stress, and neuroinflammation to propose a mechanistically novel model of PD pathogenesis. This conceptual shift highlights new opportunities for risk stratification, biomarker development, and refinement of dopaminergic therapy within iron dysregulated states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseIronHumansAnimalsOxidative StressDopamineDopaminergic NeuronsReactive Oxygen Species

Stichwörter der Autor:innen

Blood-brain barrierDopamineIron accumulationL-DOPAOxidative stressParkinson's disease

Substanzen

IronDopamineReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Neurosurgery, The Pennsylvania State University College of Medicine, Hershey, PA, USA; Penn State Neuroscience Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA; Department…
  • Department of Neurosurgery, The Pennsylvania State University College of Medicine, Hershey, PA, USA; Penn State Neuroscience Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA.

Förderung

  • NINDS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Serpa, R. O., Tufano, E., & Connor, J. R. (2026). Reimagining the contribution of iron in Parkinson's disease. Neurobiology of Disease, 225, 107434. https://doi.org/10.1016/j.nbd.2026.107434

Vancouver

Serpa RO, Tufano E, Connor JR. Reimagining the contribution of iron in Parkinson's disease. Neurobiology of Disease. 2026;225:107434. doi:10.1016/j.nbd.2026.107434

BibTeX
@article{Serpa2026,
  author = {Serpa, Rebecka O and Tufano, Emily and Connor, James R},
  title = {Reimagining the contribution of iron in Parkinson's disease},
  journal = {Neurobiology of Disease},
  year = {2026},
  volume = {225},
  pages = {107434},
  doi = {10.1016/j.nbd.2026.107434}
}
Kostenlos starten →